Clinical Trial Update: International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing multiple subcutaneous doses of BCD-085 for plaque psoriasis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• BCD-085

Snippet

Sponsor: Biocad | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2021-03-23